Elanco Animal Health Incorporated (NYSE:ELAN) saw an upside of 2.81% to close Tuesday at $12.46 after adding $0.34 on the day. The 5-day average trading volume is 9,823,141 shares of the company’s common stock. It has gained $12.72 in the past week and touched a new high 2 times within the past 5 days. An average of 7,781,910 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 7,512,356.
ELAN’s 1-month performance is 22.76% or $2.42 on its low of $10.01 reached on 07/10/23. The company’s shares have touched a 52-week low of $7.88 and high of $20.46, with the stock’s rally to the 52-week high happening on 02/02/23. YTD, ELAN has achieved 1.96% or $0.24 and has reached a new high 10 times. However, the current price is down -39.10% from the 52-week high price.
Valuation Metrics
ELAN stock has a beta of 1.01. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.39 while the price-to-book (PB) in the most recent quarter is 0.82, with the price to cash flow ratio at 35.66.
Elanco Animal Health Incorporated’s quick ratio for the period ended June 29 was 1.20, with the current ratio over the same period at 2.20. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.75, while the total debt to equity was 0.80.. In terms of profitability, the gross margin trailing 12 months is 57.30%. The trailing 12-month EBITDA margin is 24.17% while for the period ending June 29, Elanco Animal Health Incorporated’s operating margin was 5.60%. The firm’s gross profit as reported stood at $2.5 billion against revenue of $4.41 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income grew 77.32% to -$97.0 million, while revenue of $103.0 million was 206.19% off the previous quarter. Analysts expected ELAN to announce $0.05 per share in earnings in its latest quarter, but it posted $0.18, representing a 260.00% surprise. EBITDA for the quarter stood at more than $195.0 million. Shareholders hold equity totaling $492.68 million.
Let’s look briefly at Elanco Animal Health Incorporated (ELAN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 70.04% to suggest the stock is trending Overbought, with historical volatility in this time period at 28.80%.
The stock’s 5-day moving average is $11.93, reflecting a +4.09% or $0.49 change from its current price. ELAN is currently trading +18.67% above its 20-day SMA, +31.85% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +51.21% and SMA200 by+4.62%.
Stochastic %K and %D was 50.79% and 37.97% and the average true range (ATR) pointed at 0.48. The RSI (14) points at 67.90%, while the 14-day stochastic is at 79.68% with the period’s ATR at 0.45. The stock’s 9-day MACD Oscillator is pointing at 0.10 and 0.12 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Elanco Animal Health Incorporated (NYSE: ELAN), Barclays upgraded it to an Overweight rating. They previously had an Equal weight rating on the stock. Analysts offering their rating for ELAN stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate ELAN as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 3 have offered a “buy” rating.
What is ELAN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $9.00 and a high of $19.00, with their median price target at $13.50. Looking at these predictions, the average price target given by analysts is for Elanco Animal Health Incorporated (ELAN) stock is $13.44.
